Who invested in BTB Therapeutics?
BTB Therapeutics's investors include SMBC Venture Capital and Kyoto University Innovation Capital Co., Ltd.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$12Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $8.9M sold, first sale Aug 2026
Source recordedSEC filing: $3.4M sold, first sale Nov 2025
From BTB Therapeutics's own website: 1 on the team.
AdvisersAkihisa MoriKenneth W. LockeMariano A. Garcia-BlancoSilvio GutkindThomas Forest Farb-Horch
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
BTB Therapeutics's investors include SMBC Venture Capital and Kyoto University Innovation Capital Co., Ltd.
BTB Therapeutics has raised $12M across 2 rounds since 2025.
BTB Therapeutics's most recent round, $8.9M, was in Aug 2026.
Its most recent round, $8.9M in Aug 2026, is also its largest on record.
BTB Therapeutics's first round on record, in Nov 2025, was backed by SMBC Venture Capital and Kyoto University Innovation Capital Co., Ltd.
BTB Therapeutics's latest named round is a Venture, in Nov 2025.
BTB Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.